AU2021374232A1 - Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof - Google Patents
Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof Download PDFInfo
- Publication number
- AU2021374232A1 AU2021374232A1 AU2021374232A AU2021374232A AU2021374232A1 AU 2021374232 A1 AU2021374232 A1 AU 2021374232A1 AU 2021374232 A AU2021374232 A AU 2021374232A AU 2021374232 A AU2021374232 A AU 2021374232A AU 2021374232 A1 AU2021374232 A1 AU 2021374232A1
- Authority
- AU
- Australia
- Prior art keywords
- formula
- compound
- group
- reaction
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B49/00—Grignard reactions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020904060A AU2020904060A0 (en) | 2020-11-06 | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof | |
| AU2020904060 | 2020-11-06 | ||
| PCT/AU2021/051310 WO2022094668A1 (en) | 2020-11-06 | 2021-11-05 | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021374232A1 true AU2021374232A1 (en) | 2023-06-08 |
| AU2021374232A9 AU2021374232A9 (en) | 2024-09-26 |
Family
ID=81458249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021374232A Pending AU2021374232A1 (en) | 2020-11-06 | 2021-11-05 | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230416243A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4240740A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023548368A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230154789A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116981461A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021374232A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196642A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023001300A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302671A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004940A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022094668A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025073002A1 (en) * | 2023-10-03 | 2025-04-10 | Actinogen Medical Limited | Tablet formulation |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026509196A (ja) * | 2023-03-02 | 2026-03-17 | アクチノゲン メディカル リミテッド | アザ二環式ヘテロアリール化合物を調製するための流動化学プロセス |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1732552A4 (en) * | 2004-01-20 | 2007-12-19 | Merck & Co Inc | 2,6-DISUBSTITUTED PIPERIDINES AS MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY |
| MY145633A (en) * | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| ES2366058T3 (es) * | 2006-03-01 | 2011-10-14 | Theravance, Inc. | Compuestos de 8-azabiciclo[3.2.1]octano como antagonistas de los receptores opioides mu. |
| CA2738453C (en) * | 2008-10-23 | 2017-07-04 | Boehringer Ingelheim International Gmbh | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| DK2477983T3 (en) * | 2009-09-16 | 2015-06-29 | Univ Edinburgh | (4-phenyl-piperidin-1-yl) - [5-1H-pyrazol-4-yl) -thiophene-3-yl] -METHANONFORBINDELSER AND THEIR USE |
| AU2010331927B2 (en) * | 2009-12-17 | 2013-10-10 | Merck Canada Inc. | Aminopyrimidines as Syk inhibitors |
| WO2011090935A1 (en) * | 2010-01-19 | 2011-07-28 | Merck Sharp & Dohme Corp. | PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS |
| BR112012027640B1 (pt) * | 2010-04-29 | 2021-08-03 | The University Of Edinburgh | Composto, composição farmacêutica, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1 |
-
2021
- 2021-11-05 KR KR1020237018659A patent/KR20230154789A/ko active Pending
- 2021-11-05 AU AU2021374232A patent/AU2021374232A1/en active Pending
- 2021-11-05 EP EP21887915.3A patent/EP4240740A4/en active Pending
- 2021-11-05 IL IL302671A patent/IL302671A/en unknown
- 2021-11-05 MX MX2023004940A patent/MX2023004940A/es unknown
- 2021-11-05 WO PCT/AU2021/051310 patent/WO2022094668A1/en not_active Ceased
- 2021-11-05 CN CN202180088882.XA patent/CN116981461A/zh active Pending
- 2021-11-05 US US18/252,025 patent/US20230416243A1/en active Pending
- 2021-11-05 JP JP2023526903A patent/JP2023548368A/ja active Pending
- 2021-11-05 CA CA3196642A patent/CA3196642A1/en active Pending
-
2023
- 2023-05-04 CL CL2023001300A patent/CL2023001300A1/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025073002A1 (en) * | 2023-10-03 | 2025-04-10 | Actinogen Medical Limited | Tablet formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4240740A4 (en) | 2024-12-11 |
| US20230416243A1 (en) | 2023-12-28 |
| CN116981461A (zh) | 2023-10-31 |
| EP4240740A1 (en) | 2023-09-13 |
| IL302671A (en) | 2023-07-01 |
| MX2023004940A (es) | 2023-09-12 |
| AU2021374232A9 (en) | 2024-09-26 |
| CA3196642A1 (en) | 2022-05-12 |
| WO2022094668A1 (en) | 2022-05-12 |
| CL2023001300A1 (es) | 2024-01-05 |
| JP2023548368A (ja) | 2023-11-16 |
| KR20230154789A (ko) | 2023-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240059678A1 (en) | Synthesis Method for Aminopyrimidine FAK Inhibitor Compound | |
| TW201713652A (zh) | 雜環化合物的合成 | |
| CN102311448B (zh) | 噻吩并嘧啶酮类dpp-iv抑制剂 | |
| CN106946917A (zh) | 一种jak抑制剂巴瑞替尼及其中间体的新合成方法 | |
| ES2769255T3 (es) | Métodos para fabricar inhibidores de la proteína desacetilasa | |
| EP3766869A1 (en) | Simple preparation method for avibactam | |
| AU2021374232A9 (en) | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof | |
| CN102725288A (zh) | 用于制造6-取代的1-甲基-1h-苯并咪唑衍生物的方法和所述方法的中间体 | |
| CN106795174B (zh) | 一种抗病毒活性双氮氧杂环螺二酮哌嗪生物碱衍生物及其制备方法 | |
| WO2024069507A1 (en) | Synthesis methods and intermediates for the production of remibrutinib | |
| CN104876872B (zh) | 一种制备1‑叔丁氧基羰基‑3‑羟甲基吲唑的方法及应用 | |
| US20260001882A1 (en) | Process for preparing bicyclic glycine-proline compounds and monocyclic glycine-proline intermediates thereof | |
| US20210147466A1 (en) | Improved processes for the preparation of guadecitabine and intermediates thereof | |
| KR20210058817A (ko) | 브로모도메인 억제제의 제조 방법 | |
| US20250304538A1 (en) | Process of preparing remibrutinib substantially free of nitrosamine impurity | |
| CN117865966A (zh) | 氨基甲酸酯类化合物及其制备方法和医药用途 | |
| CA3268617A1 (en) | Synthesis methods and intermediates | |
| WO2026082013A1 (zh) | 一种酞嗪酮类prmt5抑制剂及其中间体的制备方法 | |
| CN119859139A (zh) | 双盐酸安罗替尼的固体形式及其制备方法 | |
| CN121511241A (zh) | 化合物的新制备方法及新结晶形式 | |
| CN116568298A (zh) | 用于制备4-(3,5-二氟苯基)-N-[3-(6-甲基嘧啶-4-基)-3-氮杂双环[3.2.1]辛烷-8-基]-6,7-二氢-5H-[1,2,4]三唑并[1,5-a]嘧啶-2-胺的方法 | |
| CN117736221A (zh) | 瑞卢戈利中间体化合物及瑞卢戈利的制备方法 | |
| CN121991162A (zh) | 一种药物偶联物中间体及制备方法 | |
| WO2013140331A1 (en) | New 1, 2, 4-oxadiazol derivatives, process for their preparation and use thereof as intermediates in the preparation of indolic alkaloids | |
| CN110172062A (zh) | 一种单氟代螺环化合物的合成方法及其中间体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ GRUGEL, CHRISTIAN AND WEDEL, TOBIAS |
|
| SREP | Specification republished |